BusinessJubilant DraxImage receives approval from Health Canada for the RUBY Elution System™ (RbES) and proprietary RUBY™ Consumable AccessoriesBy Nasdaq OMXOct 13, 2017, 3:30 PM UTC
BusinessMARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTOBy Nasdaq OMXSep 14, 2017, 11:00 AM UTC
BusinessComprehensive Study by AstraZeneca and Genentech Confirms Superiority of InSphero Human Liver Microtissues for Prediction of Drug-Induced Liver InjuryBy Nasdaq OMXJun 29, 2017, 12:00 PM UTC
BusinessTrevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain MedicationsBy Nasdaq OMXJun 20, 2017, 8:01 PM UTC
BusinessSwRI turbocharges drug discovery using mobile phone technologyBy Nasdaq OMXMay 16, 2017, 8:25 PM UTC
BusinessSwRI turbocharges drug discovery using mobile phone technologyBy Nasdaq OMXMay 16, 2017, 8:25 PM UTC
BusinessTrevena Announces Presentations at the 42nd Annual Regional Anesthesiology and Acute Pain Medicine MeetingBy Nasdaq OMXApr 6, 2017, 11:00 AM UTC
BusinessTrevena Announces Positive Top-line Results from Two Phase 3 Pivotal Efficacy Studies of Intravenous Oliceridine in Moderate-to-Severe Acute PainBy Nasdaq OMXFeb 21, 2017, 12:00 PM UTC
